Abnova (Taiwan) Corporation (TPE:4133)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
21.05
+0.50 (2.43%)
May 29, 2026, 1:30 PM CST
Market Cap1.27B -26.0%
Revenue (ttm)348.71M -3.3%
Net Income1.92M -96.0%
EPS0.03 -96.2%
Shares Out 60.55M
PE Ratio663.88
Forward PEn/a
Dividend0.11 (0.53%)
Ex-Dividend DateJun 16, 2025
Volume212,045
Open20.60
Previous Close20.55
Day's Range20.35 - 21.15
52-Week Range20.40 - 35.10
Beta0.42
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Abnova (Taiwan)

Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents. The company’s products portfolio includes SARS-CoV/CoV-2, DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, Nano, DNAxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4133
Full Company Profile

Financial Performance

Financial Statements